Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid

Virology

Volumn 257, Issue 1, 1999, Pages 261-274

  Wiegers, Klaus ^a   Rutter, Gabriel ^a   Schubert, Ulrich ^a,b   Grättinger, Mira ^a   Kräusslich, Hans Georg ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLOPHILIN A;

ARTICLE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID MEMBRANE; PLASMID; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STRUCTURE; VIRION; VIROGENESIS; VIRUS CAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0033602561     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9669     Document Type: Article

References (51)

1. Aberham C., Weber S., Phares W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 70:1996;3536-3544.
2. Ackerson B., Rey O., Canon J., Krogstad P. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J. Virol. 72:1998;303-308.
3. Adachi A., Gendelmann H. E., Koenig S., Folks T., Willey R., Rabson A., Martin M. A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
4. Billich A., Hammerschmid F., Peichl P., Wenger R., Zenke G., Quesniaux V., Rosenwirth B. Mode of action of SDZ NIM 811, a nonimmuno-suppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with HIV protein-cyclophilin A interactions. J. Virol. 69:1995;2451-2461.
5. Braaten D., Franke E. K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:1996;3551-3560.
6. Bukovsky A. A., Weimann A., Accola M. A., Göttlinger H. G. Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus fromMacaca mulatta. Proc Natl Acad Sci USA. 94:1997;10943-10948.
7. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
8. Clavel F., Charneau P. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1994;1179-1185.
9. Craven R. C., Parent L. J. Dynamic interactions of the Gag polyprotein. Curr. Top. Microbiol. Immunol. 214:1996;65-94.
10. Dorfman T., Bukovsky A., Öhagen A., Höglund S., Göttlinger H. G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994;8180-8187.
11. Dorfman T., Göttlinger H. G. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70:1996;5751-5757.
12. Emerman M. HIV-1, Vpr and the cell cycle. Curr. Biol. 6:1996;1096-1103.
13. Folks T., Benn S., Rabson A., Theodore T., Hoggan M. D., Martin M., Lightfoote M., Sell K. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)- associated retrovirus. Proc Natl Acad Sci USA. 82:1985;4539-4543.
14. Franke E. K., Yuan H. E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature. 372:1994;359-362.
15. Freeman B. C., Toft D. O., Morimoto R. I. Molecular chaperone machines: Chaperone activities of the cyclophilin Cyp-40 and the steroid aporeceptor-associated protein p23. Science. 274:1996;1718-1720.
16. Fuller S. D., Wilk T., Gowen B. E., Kräusslich H. G., Vogt V. M. Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr. Biol. 7:1997;729-738.
17. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:1995;569-576.
18. Gamble T. R., Vajdos F. F., Yoo S., Worthylake D. K., Houseweart M., Sundquist W. I., Hill C. P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 87:1996;1285-1294.
19. Gelderblom H. R. Assembly and morphology of HIV: Potential effect of structure on viral function (Editorial). AIDS. 5:1991;617-637.
20. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell. 59:1989;103-112.
21. Gitti R. K., Lee B. M., Walker J., Summers M. F., Yoo S., Sundquist W. I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 273:1996;231-235.
22. Grättinger M., Hohenberg H., Thomas D., Wilk T., Müller B., Kräusslich H. G. In vitro. Virology. 257:1999;247-260.
23. Harada S., Koyanagi Y., Yamamoto N. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science. 229:1985;563-566.
24. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
25. Kohl N. E., Emini E. A., Schleif W. A., Davis L. J., Heimbach J. C., Dixon R. A., Scolnick E. M., Sigal I. S. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA. 85:1988;4686-4690.
26. Konvalinka J., Litterst M. A., Welker R., Kottler H., Rippmann F., Heuser A. M., Kräusslich H. G. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J. Virol. 69:1995;7180-7186.
27. Kräusslich H. G., Wimmer E. Viral proteinases. Annu. Rev. Biochem. 57:1988;701-754.
28. Kuo L. C., Shafer A. C. Retroviral proteases. Methods Enzymol. 241:1994.
29. Leis J., Baltimore D., Bishop J. M., Coffin J., Fleissner E., Goff S. P., Oroszlan S., Robinson H., Skalka A. M., Temin H. M. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62:1988;1808-1809.
30. Lilie H., Lang K., Rudolph R., Buchner J. Prolyl isomerases catalyze antibody folding in vitro. Prot. Sci. 2:1993;1490-1496.
31. Liu H., Wu X., Newman M., Shaw G. M., Hahn B. H., Kappes J. C. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:1995;7630-7638.
32. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73:1993;1067-1078.
33. Mergener K., Fäcke M., Welker R., Brinkmann V., Gelderblom H. R., Kräusslich H. G. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology. 186:1992;25-39.
34. Öhagen A., Luftig R. B., Reicin A. S., Yin L., Ikuta K., Kimura T., Goff S. P., Höglund S. The morphology of the immature HIV-1 virion. Virology. 228:1997;112-114.
35. Ratner L., Fisher A., Jagodzinski L. L., Mitsuya H., Liou R. S., Gallo R. C., Wong-Staal F. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retroviruses. 3:1987;57-69.
36. Reicin A. S., Paik S., Berkowitz R. D., Luban J., Lowy I., Goff S. P. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:1995;642-650.
37. Rose J. R., Babe L. M., Craik C. S. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 69:1995;2751-2758.
38. Salahuddin S. Z., Markham P. D., Wong-Staal F., Franchini G., Kalyanaraman V. S., Gallo R. C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology. 129:1983;51-64.
39. Schubert U., Anton L. C., Bacik I., Cox J. H., Bour S., Bennink J. R., Orlowski M., Strebel K., Yewdell J. W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72:1998;2280-2288.
40. Schubert U., Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:1994;2260-2271.
41. Schulz T. F., Whitby D., Hoad J. G., Corrah T., Whittle H., Weiss R. A. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J. Virol. 64:1990;5177-5182.
42. Shields R., Witte O. N., Rothenberg R., Baltimore D. High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell. 14:1978;601-609.
43. Spurr A. R. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26:1969;31-43.
44. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolff B., Peichl P., Palfi G., Schnitzel W., Mlynar E. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV- 1): Interference with early and late events in HIV-1 replication. J. Virol. 69:1995;814-824.
45. Streblow D. N., Kitabwalla M., Malkovsky M., Pauza C. D. Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. Virology. 245:1998;197-202.
46. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Göttlinger H. G. Functional association of cyclophilin A with HIV-1 virions. Nature. 372:1994;363-365.
47. Wang C. T., Barklis E. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J. Virol. 67:1993;4264-4273.
48. Wiegers K., Rutter G., Kottler H., Tessmer U., Hohenberg H., Kräusslich H. G. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:1998;2846-2854.
49. Wills J. W., Craven R. C. Form, function, and use of retroviral gag proteins. AIDS. 5:1991;639-654.
50. Yin L., Braaten D., Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J. Virol. 72:1998;6430-6436.
51. Yoo S., Myszka D. G., Yeh C., McMurray M., Hill C. P., Sundquist W. I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:1997;780-795.